Tyra Biosciences, Inc. (TYRA)
NASDAQ: TYRA · Real-Time Price · USD
31.94
-0.17 (-0.53%)
At close: Jun 30, 2026, 4:00 PM EDT
32.01
+0.07 (0.22%)
After-hours: Jun 30, 2026, 7:59 PM EDT
Tyra Biosciences Market Cap
Tyra Biosciences has a market cap or net worth of $1.9 billion as of June 30, 2026. Its market cap has increased by 242.47% in one year.
Market Cap
1.90B
Enterprise Value
1.52B
1-Year Change
242.47%
Ranking
Category
Stock Price
$31.94
Market Cap Chart
Since the IPO on September 15, 2021, Tyra Biosciences's market cap has increased from $654.64M to $1.90B, an increase of 190.16%. That is a compound annual growth rate of 24.90%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 30, 2026 | 1.90B | 35.37% |
| Dec 31, 2025 | 1.40B | 91.90% |
| Dec 31, 2024 | 731.18M | 22.61% |
| Dec 29, 2023 | 596.34M | 87.61% |
| Dec 30, 2022 | 317.87M | -44.42% |
| Dec 31, 2021 | 571.90M | -12.64% |
| Sep 15, 2021 | 654.64M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Absci | 1.96B |
| Bicara Therapeutics | 1.95B |
| Recursion Pharmaceuticals | 1.95B |
| AtaiBeckley | 1.94B |
| ADMA Biologics | 1.94B |
| Syndax Pharmaceuticals | 1.94B |
| Zymeworks | 1.91B |
| Sarepta Therapeutics | 1.90B |